Pular para o conteúdo principal
Ranking Invest

REPH - Recro Pharma, Inc.

Segmento: HealthcareRecro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Análise Ranking Invest

Valuation estimado
-$ 22.77 Mi
Último Balanço Atualizado: 4T2023

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 58.66 Mi

Dívida Líquida

$ 33.92 Mi

L4T

-$ 13.27 Mi

MM4T

-14.70%

Indicadores Básicos

ROE

-22.63%

Índices de Previsibilidade

Receita Líquida

D0.11

Lucro

C0.42

Margem

C0.42

Índices de Tendência

Receita Líquida

B8.31

Lucro

C2.74

Margem

C3.46

Índices de Endividamento

DIV/PAT

0.58

DIV/L4T

-2.56

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.